What is MetaVia Inc.'s earnings per share (EPS)?

MetaVia Inc. (MTVA) reported diluted earnings per share of -$7.35 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MetaVia Inc. (MTVA) Financials

MTVA

FY2025 annual

Net Income -$13.0M +53.0% YoY

EPS (Diluted) -$7.35 YoY not available

Free Cash Flow -$15.7M +36.5% YoY

Operating Cash Flow -$15.7M +36.5% YoY

Market Cap $9.3M as of Oct 10, 2026

Price / Sales n/m no revenue reported

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 1.4x on $6.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MTVA SEC filings page.

This page shows MetaVia Inc. (MTVA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MTVA FY2025 2026-10-03

MetaVia operates as a cash-consuming development-stage business: losses narrowed in FY2025, but external financing still funded its balance sheet.

FY2025’s net loss of $13.0M was close to operating cash flow of -$15.7M. Free cash flow was also -$15.7M, so the gap was not being created by large capital spending; earnings and cash largely tell the same operating story.

The operating loss narrowed from $28.8M in FY2024 to $13.7M in FY2025. R&D fell from $21.6M to $6.8M over the same period, so the improvement is more consistent with reduced spending than demonstrated operating leverage.

Assets fell from $16.3M in FY2024 to $11.1M in FY2025. With debt-to-equity at 1.1x and $10.0M of financing inflow, the smaller asset base is increasingly supported by external capital rather than internally generated cash.

Financial Health Signals

Financial health score not available

MetaVia Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

2/6

MetaVia Inc. passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

N/A

MetaVia Inc. reported a net loss of $13.0M while operations used $15.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

MetaVia Inc. reported an operating loss of $13.7M against $510K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$5.4M

YoY-25.3%

QoQ-33.9%

MetaVia Inc.'s EBITDA was -$5.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.3% from the same quarter a year earlier. Against the prior quarter it is down 33.9%.

Net Income

-$5.3M

YoY-33.1%

QoQ-39.1%

MetaVia Inc. reported -$5.3M in net income in Q2 2026. This represents a decrease of 33.1% from the same quarter a year earlier. Against the prior quarter it is down 39.1%.

EPS (Diluted)

-$0.90

QoQ-13.9%

MetaVia Inc. earned -$0.90 per diluted share (EPS) in Q2 2026. Against the prior quarter it is down 13.9%.

Revenue

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$12.6M

YoY-28.2%

QoQ-8.0%

5Y CAGR+5.8%

10Y CAGR+10.1%

MetaVia Inc. held $12.6M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

QoQ+27.6%

5Y CAGR-21.6%

10Y CAGR-3.4%

MetaVia Inc. had 7M shares outstanding in Q2 2026. Against the prior quarter it is up 27.6%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity

-77.9%

YoY-36.4pp

QoQ-35.8pp

MetaVia Inc.'s ROE was -77.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 36.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 35.8 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$3.5M

YoY+49.9%

QoQ+65.5%

MetaVia Inc. invested $3.5M in research and development in Q2 2026. This represents an increase of 49.9% from the same quarter a year earlier. Against the prior quarter it is up 65.5%.

Share Buybacks

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

MTVA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MTVA quarterly income statement

Metric	TTM	FY25DEF 14A	FY24DEF 14A	FY23DEF 14A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K
R&D Expenses	N/A	$6.8M-68.4%	$21.6M+135.3%	$9.2M+229.7%	$2.8M-57.6%	$6.5M+44.5%	$4.5M-14.9%	$5.3M+5.1%	$5.1M-77.7%	$22.7M+159.6%	$8.7M+119.0%	$4.0M+7575.0%	$52K
SG&A Expenses	N/A	$6.9M-4.8%	$7.3M+7.8%	$6.7M-22.1%	$8.6M-1.3%	$8.8M+11.5%	$7.8M+190.5%	$2.7M+68.3%	$1.6M-84.6%	$10.4M+75.3%	$6.0M+87.5%	$3.2M+1384.6%	$214K
Operating Income	N/A	-$13.7M+52.4%	-$28.8M-81.3%	-$15.9M+19.1%	-$19.6M-28.3%	-$15.3M+48.5%	-$29.7M-47.3%	-$20.2M-30.3%	-$15.5M+53.2%	-$33.1M-125.4%	-$14.7M-82.0%	-$8.1M-2936.1%	-$266K
EBITDA	N/A	-$13.7M+52.5%	-$28.8M-81.3%	-$15.9M+19.0%	-$19.6M-28.6%	-$15.3M+48.6%	-$29.7M-47.2%	-$20.2M	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$510K-44.6%	$920K+99.6%	$461K	N/A	$14K-64.1%	$39K+277.3%	-$22K+45.0%	-$40K+86.0%	-$286K-350.9%	$114K+115.0%	-$762K-1285.5%	-$55K
Income Tax	N/A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A	N/A
Net Income	N/A	-$13.0M+53.0%	-$27.6M-121.3%	-$12.5M+10.7%	-$14.0M+8.6%	-$15.3M+48.5%	-$29.7M-39.3%	-$21.3M-37.2%	-$15.5M+53.5%	-$33.4M-129.1%	-$14.6M-61.5%	-$9.0M-2721.6%	-$320K
EPS (Basic)	N/A	-$7.35+81.2%	-$39.13-1490.7%	-$2.46+94.3%	-$43.42-119.2%	-$19.81-982.5%	-$1.83	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	—	-$7.35	-$39.13	-$2.46	-$43.42	-$19.81	-$1.83	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	2M	705,193	5M	321,703	771,422	16M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
R&D Expenses	$3.5M+49.9%	$2.1M-9.7%	N/A	$1.9M-57.6%	$2.3M-71.3%	$2.3M-52.5%	N/A	$4.5M+97.1%
SG&A Expenses	$1.9M-3.7%	$1.9M+23.4%	N/A	$1.6M-10.4%	$2.0M-1.4%	$1.6M-21.1%	N/A	$1.7M+8.8%
Operating Income	-$5.4M-25.2%	-$4.0M-3.6%	N/A	-$3.5M+44.5%	-$4.3M+57.3%	-$3.9M+43.5%	N/A	-$6.3M-60.8%
EBITDA	-$5.4M-25.3%	-$4.0M-3.6%	N/A	-$3.5M+44.5%	-$4.3M+57.4%	-$3.9M+43.6%	N/A	-$6.3M-60.7%
Interest Expense	$73K-50.0%	$85K-33.6%	N/A	$151K-51.3%	$146K-11.0%	$128K-46.0%	N/A	$310K+91.4%
Income Tax	$0	$0	N/A	$0	$0	$0	N/A	$0
Net Income	-$5.3M-33.1%	-$3.8M-4.1%	N/A	-$3.4M+40.3%	-$4.0M+60.3%	-$3.7M+45.3%	N/A	-$5.7M-48.0%
EPS (Basic)	-$0.90+68.6%	-$0.79+79.9%	-$6.72-2000.0%	-$0.14+74.5%	-$2.87-55.1%	-$3.93-197.7%	-$0.32+69.5%	-$0.55+26.7%
EPS (Diluted)	-$0.90	-$0.79	-$6.72-2000.0%	-$0.14	-$2.87	-$3.93	-$0.32+69.5%	-$0.55
Diluted Shares (Avg)	6M	5M	N/A	24M	1M	933,109	N/A	10M

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit.

MTVA Balance Sheet

MTVA quarterly balance sheet

Metric	FY25DEF 14A	FY24DEF 14A	FY23DEF 14A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K
Total Assets	$11.1M-31.6%	$16.3M-28.6%	$22.8M-32.1%	$33.5M+99.6%	$16.8M+53.2%	$11.0M-24.2%	$14.5M+278.7%	$3.8M-79.9%	$19.0M-23.2%	$24.8M+451.3%	$4.5M	N/A
Current Assets	$10.9M-32.3%	$16.1M-28.6%	$22.5M-32.9%	$33.5M+102.2%	$16.6M+55.2%	$10.7M-24.3%	$14.1M+270.7%	$3.8M-80.0%	$19.0M-23.2%	$24.7M+579.3%	$3.6M	N/A
Cash & Equivalents	$10.3M-35.8%	$16.0M-28.6%	$22.4M-32.8%	$33.4M+103.6%	$16.4M+62.4%	$10.1M-27.5%	$13.9M+388.9%	$2.8M-84.6%	$18.5M-23.1%	$24.0M+563.9%	$3.6M+1042.0%	$317K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$5.8M-30.5%	$8.3M+36.6%	$6.1M-48.3%	$11.8M+435.1%	$2.2M-41.5%	$3.8M+73.0%	$2.2M-87.3%	$17.1M-9.9%	$19.0M+360.7%	$4.1M-75.6%	$16.9M	N/A
Current Liabilities	$5.6M-31.7%	$8.3M+38.8%	$6.0M-49.4%	$11.8M+446.3%	$2.2M-41.6%	$3.7M+77.5%	$2.1M+850.7%	$219K-96.6%	$6.4M+55.1%	$4.1M-53.8%	$8.9M	N/A
Non-Current Liabilities	$142K+144.8%	$58K-57.4%	$136K	$0-100.0%	$45K-35.7%	$70K-25.5%	$94K-99.4%	$16.9M+34.0%	$12.6M+1260100.0%	$1K-100.0%	$8.0M	N/A
Total Equity	$5.3M-32.8%	$7.9M-52.5%	$16.7M-23.3%	$21.8M+49.0%	$14.6M+102.7%	$7.2M-41.4%	$12.3M+192.5%	-$13.3M-53244.0%	$25K-99.9%	$20.6M+266.7%	-$12.4M-2231.5%	-$531K
Retained Earnings	-$148.8M-9.5%	-$135.9M-25.5%	-$108.3M-13.0%	-$95.8M-17.1%	-$81.8M-23.0%	-$66.5M-80.5%	-$36.9M-137.0%	-$15.6M+74.3%	-$60.5M-123.5%	-$27.1M-118.4%	-$12.4M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$13.3M-28.1%	$14.4M+18.6%	$11.1M-31.6%	$14.8M-33.3%	$18.5M-35.8%	$12.1M-28.7%	$16.3M-28.6%	$22.1M-16.2%
Current Assets	$13.1M-28.7%	$14.2M+18.4%	$10.9M-32.3%	$14.6M-33.2%	$18.3M-35.8%	$12.0M-28.7%	$16.1M-28.6%	$21.9M-16.1%
Cash & Equivalents	$12.6M-28.2%	$13.7M+22.7%	$10.3M-35.8%	$14.3M-34.1%	$17.6M-37.0%	$11.2M-30.0%	$16.0M-28.6%	$21.7M-16.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$6.4M-27.0%	$5.3M-31.4%	$5.8M-30.5%	$8.4M-8.3%	$8.8M-9.9%	$7.7M+11.6%	$8.3M+36.6%	$9.2M+88.6%
Current Liabilities	$6.3M-28.0%	$5.2M-32.7%	$5.6M-31.7%	$8.4M-7.5%	$8.8M-9.2%	$7.7M+13.0%	$8.3M+38.8%	$9.1M+93.0%
Non-Current Liabilities	$103K+586.7%	$123K+232.4%	$142K+144.8%	$0-100.0%	$15K-84.7%	$37K-68.4%	$58K-57.4%	$79K-48.4%
Total Equity	$6.8M-29.1%	$9.1M+107.1%	$5.3M-32.8%	$6.3M-51.1%	$9.6M-49.2%	$4.4M-56.5%	$7.9M-52.5%	$13.0M-39.9%
Retained Earnings	-$158.0M-10.1%	-$152.7M-9.4%	-$148.8M-9.5%	-$146.9M-12.4%	-$143.5M-14.8%	-$139.5M-21.4%	-$135.9M-25.5%	-$130.7M-26.9%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

MTVA Cash Flow Statement

MTVA quarterly cash flow statement

Metric	TTM	FY25DEF 14A	FY24DEF 14A	FY23DEF 14A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K
Operating Cash Flow	-$15.8M	-$15.7M+36.5%	-$24.7M-128.8%	-$10.8M+7.8%	-$11.7M+22.6%	-$15.1M-40.6%	-$10.8M-52.9%	-$7.0M+51.3%	-$14.5M+46.3%	-$26.9M-143.6%	-$11.0M-103.3%	-$5.4M-2686.2%	-$195K
Depreciation & Amortization	N/A	$19K-5.0%	$20K+233.3%	$6K-70.0%	$20K-58.3%	$48K+4.3%	$46K+170.6%	$17K	N/A	N/A	N/A	N/A	N/A
Stock-Based Compensation	N/A	$411K-23.6%	$538K+142.3%	$222K-74.0%	$854K+29.0%	$662K-5.3%	$699K+492.4%	$118K-97.1%	$4.1M-21.7%	$5.3M+206.9%	$1.7M+504.9%	$284K+435.8%	$53K
Capital Expenditures	N/A	$2K-75.0%	$8K-84.0%	$50K	N/A	$3K-25.0%	$4K-98.1%	$214K+7033.3%	$3K	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$15.7M+36.5%	-$24.7M-127.8%	-$10.8M	N/A	-$15.1M-40.6%	-$10.8M-48.5%	-$7.3M+49.8%	-$14.5M	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	-$2K+75.0%	-$8K+84.0%	-$50K-725.0%	$8K+101.4%	-$586K-949.3%	$69K+101.1%	-$6.1M-201800.0%	-$3K	N/A	N/A	N/A	N/A
Financing Cash Flow	$10.9M	$10.0M-45.6%	$18.3M+22975.0%	-$80K-100.3%	$28.7M+30.2%	$22.0M+221.2%	$6.9M-71.6%	$24.2M+40.1%	$17.2M-19.2%	$21.3M-32.2%	$31.5M+260.1%	$8.7M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$3.8M-22.5%	-$4.3M+11.6%	-$4.9M+11.1%	-$3.0M+46.7%	-$3.1M+57.6%	-$4.8M+25.3%	-$5.5M-61.2%	-$5.5M-97.2%
Depreciation & Amortization	$4K-20.0%	$5K+25.0%	$5K0.0%	$5K0.0%	$5K-16.7%	$4K0.0%	$5K+25.0%	$5K+400.0%
Stock-Based Compensation	$130K+17.1%	$100K-24.2%	N/A	$97K-30.2%	$111K-17.8%	$132K+25.7%	N/A	$139K-19.2%
Capital Expenditures	N/A	N/A	$0	$0	N/A	N/A	$0-100.0%	$0-100.0%
Free Cash Flow	N/A	N/A	-$4.9M+11.1%	-$3.0M+46.7%	N/A	N/A	-$5.5M-60.8%	-$5.5M-94.6%
Investing Cash Flow	N/A	N/A	$0	$0	N/A	N/A	$0+100.0%	$0+100.0%
Financing Cash Flow	$2.7M-71.9%	$7.7M+64358.3%	$861K+570.5%	-$357K+50.2%	$9.5M	-$12K	-$183K	-$717K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MTVA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MTVA quarterly financial ratios

Metric	FY25DEF 14A	FY24DEF 14A	FY23DEF 14A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K
Return on Equity	-243.3%+104.6pp	-347.9%-273.2pp	-74.7%-10.5pp	-64.2%+40.5pp	-104.7%+307.3pp	-412.0%-238.6pp	-173.4%	N/A	-133660.0%-133589.3pp	-70.7%	N/A	N/A
Return on Assets	-116.6%+53.1pp	-169.7%-115.0pp	-54.7%-13.1pp	-41.6%+49.3pp	-91.0%+179.6pp	-270.6%-123.3pp	-147.3%+259.2pp	-406.5%-230.8pp	-175.7%-116.8pp	-58.9%+142.2pp	-201.1%	N/A
Current Ratio	1.930.0x	1.94-1.8x	3.78+0.9x	2.85-4.8x	7.69+4.8x	2.89-3.9x	6.78-10.6x	17.39+14.4x	2.97-3.0x	6.00+5.6x	0.41	N/A
Debt-to-Equity	1.090.0x	1.05+0.7x	0.37-0.2x	0.54+0.4x	0.15-0.4x	0.52+0.3x	0.18	N/A	759.68+759.5x	0.20	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Return on Equity	-77.9%-36.4pp	-42.1%+41.7pp	N/A	-53.3%-9.7pp	-41.5%+11.6pp	-83.8%-17.2pp	N/A	-43.6%-25.9pp
Return on Assets	-40.1%-18.4pp	-26.6%+3.7pp	N/A	-22.9%+2.6pp	-21.6%+13.3pp	-30.3%+9.2pp	N/A	-25.5%-11.1pp
Current Ratio	2.060.0x	2.73+1.2x	1.930.0x	1.74-0.7x	2.08-0.9x	1.55-0.9x	1.94-1.8x	2.41-3.1x
Debt-to-Equity	0.950.0x	0.59-1.2x	1.090.0x	1.33+0.6x	0.92+0.4x	1.77+1.1x	1.05+0.7x	0.71+0.5x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
MetaVia Inc. MTVA	FY2025	N/A	-$13.0M	N/A	$9.3M	—
Tharimmune, Inc. THAR	FY2025	N/A	-$35.9M	N/A	$187.4M	—
Lipocine Inc. LPCN	FY2025	$2.0M	-$9.6M	N/A	$15.9M	53/100
Portage Biotech Inc. PRTG	FY2018	N/A	$123.7M	N/A	$15.5M	—
Pulmatrix, Inc. PULM	FY2025	N/A	-$5.2M	N/A	$5.6M	—
SYNLOGIC INC SYBX	FY2025	$0	-$1.0M	N/A	$6.6M	—

Where MetaVia Inc. Ranks

Frequently Asked Questions

Is MetaVia Inc. profitable?

No, MetaVia Inc. (MTVA) reported a net income of -$13.0M in fiscal year 2025.

What is MetaVia Inc.'s EBITDA?

MetaVia Inc. (MTVA) had EBITDA of -$13.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is MetaVia Inc.'s return on equity (ROE)?

MetaVia Inc. (MTVA) has a return on equity of -243.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is MetaVia Inc.'s free cash flow?

MetaVia Inc. (MTVA) recorded an outflow of $15.7M in free cash flow during fiscal year 2025. This represents a 36.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MetaVia Inc.'s operating cash flow?

MetaVia Inc. (MTVA) recorded an outflow of $15.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are MetaVia Inc.'s total assets?

MetaVia Inc. (MTVA) had $11.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are MetaVia Inc.'s capital expenditures?

MetaVia Inc. (MTVA) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does MetaVia Inc. spend on research and development?

MetaVia Inc. (MTVA) invested $6.8M in research and development during fiscal year 2025.

How many shares does MetaVia Inc. have outstanding?

MetaVia Inc. (MTVA) had 5M shares outstanding as of fiscal year 2025.

What is MetaVia Inc.'s current ratio?

MetaVia Inc. (MTVA) had a current ratio of 1.93 as of fiscal year 2025, which is generally considered healthy.

What is MetaVia Inc.'s debt-to-equity ratio?

MetaVia Inc. (MTVA) had a debt-to-equity ratio of 1.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MetaVia Inc.'s return on assets (ROA)?

MetaVia Inc. (MTVA) had a return on assets of -116.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is MetaVia Inc.'s P/E ratio?

MetaVia Inc. (MTVA) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $9.3M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is MetaVia Inc.'s price-to-sales ratio?

MetaVia Inc. (MTVA) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $9.3M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does MetaVia Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, MetaVia Inc. (MTVA) held $10.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $15.7M over that year. Dividing the one by the other, the reported balance equals about 8 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is MetaVia Inc.'s Piotroski F-Score?

MetaVia Inc. (MTVA) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MetaVia Inc.'s earnings high quality?

MetaVia Inc. (MTVA) reported a net loss of $13.0M while operations used $15.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can MetaVia Inc. cover its interest payments?

MetaVia Inc. (MTVA) reported an operating loss of $13.7M against $510K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.